Global Pulmonary Embolectomy System Market Strategic Research Report

Scope of the Report

The global Pulmonary Embolectomy System market size is predicted to grow from US$ 1,086 million in 2025 to US$ 1,849 million in 2032; it is expected to grow at a CAGR of 7.9% from 2026 to 2032.

Pulmonary embolectomy systems are specialized medical devices designed for the minimally invasive removal of thromboemboli from the pulmonary arteries to restore hemodynamic stability in patients with acute pulmonary embolism. These systems typically comprise aspiration catheters, mechanical thrombectomy devices, guidewires, and negative pressure aspiration pumps. Unlike traditional surgical embolectomy, catheter-based techniques achieve thrombus removal through percutaneous access, offering reduced procedural trauma, shorter hospital stays, and improved clinical outcomes for intermediate- and high-risk patients. Key technologies include large-bore aspiration catheters, mechanical fragmentation devices, and rheolytic thrombectomy systems. From a value chain perspective, upstream includes catheter material suppliers (medical-grade polymers, braiding wires), guidewire component manufacturers, aspiration pump and console producers, and packaging/sterilization service providers; midstream involves device assembly, quality control, regulatory certification (FDA, CE, NMPA), and distribution; downstream demand spans interventional cardiology departments, vascular surgery departments, interventional radiology departments, and intensive care units in hospitals. In 2025, the average selling price is approximately US$9,800 per unit, global sales volume is about 113.3k units, and gross margins generally range from 50% to 70%, driven by catheter material costs, device design complexity, regulatory approval barriers, and physician training requirements.

The pulmonary embolectomy system market is experiencing robust growth driven by the increasing global incidence of pulmonary embolism and the paradigm shift toward minimally invasive catheter-based interventions over traditional surgical embolectomy. According to the CDC, approximately 900,000 people in the United States are affected by deep vein thrombosis and pulmonary embolism annually, with about 60,000-100,000 deaths. This high disease burden, coupled with the availability of effective mechanical thrombectomy devices, has created substantial demand for pulmonary embolectomy systems.

Another key trend is the expansion of treatment guidelines that now recommend catheter-directed therapies for intermediate-risk pulmonary embolism patients. Previously, systemic anticoagulation was the standard of care for non-massive PE, but growing evidence supports the use of mechanical thrombectomy to reduce right ventricular strain, improve long-term functional outcomes, and prevent chronic thromboembolic pulmonary hypertension. This guideline expansion has significantly broadened the addressable patient population for pulmonary embolectomy systems.

The market is also witnessing significant technological innovation in next-generation thrombectomy devices. Key trends include the development of dual-action devices combining aspiration and mechanical fragmentation, enhanced navigability through complex pulmonary arterial anatomy, and real-time pressure monitoring for safer aspiration. These innovations are improving procedural efficienc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pulmonary Embolectomy System market?

What factors are driving Pulmonary Embolectomy System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pulmonary Embolectomy System market opportunities vary by end market size?

How does Pulmonary Embolectomy System break out by Type, by Application?

This report presents a comprehensive overview of the global Pulmonary Embolectomy System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Large-Bore Aspiration Catheter (> 12F)
• Medium-Bore Aspiration Catheter (8-12F)
• Small-Bore Aspiration Catheter (< 8F)

Segment by Price Tier

• Standard (< US$7,000)
• Premium (US$7,000-15,000)
• Integrated System (> US$15,000)

Segment by Patient Risk Stratification

• High-Risk PE (Massive)
• Intermediate-Risk PE (Submassive)
• Low-Risk PE

Segment by Application

• Tertiary / Academic Medical Center
• Regional / Community Hospital
• Specialized Cardiovascular Center

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pulmonary Embolectomy System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Tertiary / Academic Medical Center, Regional / Community Hospital, Specialized Cardiovascular Center evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact